SCHEMBL14009154

SCHEMBL14009154

COc1ccccc1NC(=O)c1ccc(C(=O)Nc2ccc(-n3cncn3)cc2)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ MAPT P10636 6/20 0.48
▸ TP53 P04637 2/20 0.48
▸ KMT2A Q03164 2/20 0.47
▸ APLNR P35414 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009049 0.91 NAMPT (0.46) SMN1; SMN2MAPTTP53KMT2AKDM4E
SCHEMBL14009001 0.86 KDM4E (0.53) MAPTKMT2AKDM4ENPC1RAB9A
SCHEMBL14009057 0.86 KMT2A (0.53) MAPTTP53KMT2ANPC1RAB9A
SCHEMBL14009215 0.85 KMT2A (0.49) SMN1; SMN2MAPTTP53KMT2AKDM4E
SCHEMBL14008925 0.85 SMN1; SMN2 (0.54) SMN1; SMN2MAPTTP53KMT2AKDM4E
SCHEMBL14009325 0.85 KMT2A (0.52) SMN1; SMN2MAPTKMT2AAPLNRKDM4E
SCHEMBL14009163 0.85 ROCK1 (0.51) SMN1; SMN2MAPTTP53KMT2AKDM4E
SCHEMBL14009252 0.84 RAB9A (0.47) SMN1; SMN2MAPTKMT2AKDM4EHPGD
SCHEMBL14009251 0.84 KMT2A (0.51) SMN1; SMN2MAPTTP53KMT2AKDM4E
SCHEMBL14009219 0.84 KMT2A (0.53) SMN1; SMN2MAPTTP53KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 SMN1; SMN2 2211/4885MAPT 2145/4885TP53 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback